Pharmafile Logo
Pharmafocus logo
Advanced Search

Genzyme

Showing 15 posts of 98 posts found.

Termeer exit could help Sanofi

September 30, 2010
Sales and Marketing Genzyme, M&A, MA, Sanofi

Genzyme’s chief executive Henri Termeer has signalled he will retire next year, a move which would help smooth the way …

News

Genzyme planning 1,000 job cuts

September 14, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, job cuts

Genzyme has said it intends to cut back its workforce by around 1,000 over the next 15 months in order …

News

Genzyme available for ‘fair value’, says Termeer

September 2, 2010
Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Genzyme’s chief executive Henri Termeer has said his company could be for sale to Sanofi-Aventis if it offers a ‘fair …

News

Sanofi’s $18.5bn bid for Genzyme rejected

August 31, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis has gone public with its $18.5 billion offer for Genzyme after the US biotech’s board unanimously rejected the bid …

News

Cohn & Wolfe wins MS account

August 20, 2010
Medical Communications Cohn & Wolfe, Genzyme, MS

Cohn & Wolfe has won a global account with Genzyme to handle communications for its work with alemtuzumab in multiple …

News

Cell therapy industry partnership launched

August 18, 2010
Research and Development Genzyme, ISCT, Lonza, Roche

Pharma and biotech companies including Roche and Genzyme are to launch a series of initiatives to bolster progress in the …

News

Genzyme posts loss after inventory write-off

August 12, 2010
Manufacturing and Production, Sales and Marketing Genzyme, manufacturing compliance

Genzyme has had to write off an additional tranche of product that does not meet quality standards, forcing it to …

News

Sanofi’s blockbusters take a hit

July 29, 2010
Sales and Marketing 2010 financials, Genzyme, Q2, Sanofi-Aventis

Generic pressures, European pricing pressures and the impact of the US health reforms combined to dent Sanofi-Aventis’s growth in the …

News
Genzyme

Genzyme ponders Sanofi offer

July 27, 2010
Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis is understood to have approached the board of Genzyme with a takeover bid for the company. News agency Reuters …

News
Genzyme

Manufacturing woes hit Genzyme results

July 22, 2010
2010 financials, Genzyme, Q2

Genzyme has posted a decrease in sales for the second quarter as its manufacturing woes continue. The US-based biopharma company …

News

Genzyme says it will double size of its Framingham site

July 13, 2010
Manufacturing and Production Genzyme

Genzyme has unveiled a major expansion of its manufacturing facility in Framingham, Massachusetts, which suggests that the company intends to …

News
GenzymeGate

EMA panel advises Fabrazyme switch

July 7, 2010
Manufacturing and Production Fabrazyme, Genzyme, manufacturing compliance

Doctors in Europe have been told they should consider switching patients with Fabry disease away from treatment with Genzyme’s Fabrazyme …

News

More woe for Genzyme as shipping delays continue

July 6, 2010
Manufacturing and Production Cerezyme, Fabrazyme, Gaucher, Genzyme, manufacturing compliance

Genzyme is expecting further delays in shipments of two key products as it struggles to bring its troubled Allston Landing …

News
NHS Football Fitness

Digital Pharma: Byte-sized roundup

June 18, 2010
Medical Communications, Research and Development FDA, Genzyme, NHS, Pfizer, digital pharma med coms, digital pharma research, social media

This week’s roundup includes an NHS football fitness game, Pfizer’s virtual exhibition booth, Amgen’s oncology site, reports FDA social media …

News
Genzyme

Genzyme and Icahn agree compromise deal

June 10, 2010
Research and Development, Sales and Marketing Genzyme

Carl Icahn has won his battle with Genzyme to have his associates given a place on the company’s board.The US …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026